Enliven Therapeutics, Inc. ELVN
50.31 USD -1.24 (-2.41%)
Nov 10, 2026, 12:20 PM EST
49.74 Day range 51.35
14.79 52-week range 62.32
- YTD
- +226.69%
- 1 year
- +168.89%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -119.66M | -104.55M | -83.53M | -38.79M | -51.44M | |
| -103.69M | -89.02M | -71.58M | -37.66M | -51.38M | |
| -1.83 | -1.89 | -2.01 | -12.05 | -9.50 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 98.90M | 124.17M | 100.19M | 75.59M | 48.31M | |
| 476.17M | 325.76M | 271.87M | 83.30M | 93.65M | |
| 16.57M | 15.91M | 25.96M | 10.37M | 7.62M | |
| 459.60M | 309.85M | 245.91M | -76.83M | 86.03M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -70.30M | -73.19M | -61.27M | -32.08M | -46.77M | |
| -173.84M | -36.00M | -148.41M | -612.00K | -1.63M | |
| 218.87M | 133.16M | 234.29M | -1.80M | 49.10M | |
| 55.00K | -44.00K | -149.00K | -612.00K | -12.00K | |
| -25.27M | 23.98M | 24.61M | -34.49M | 698.00K |